Live Meeting Request

Interested in hosting a Biosimilars activity? The Biosimilars faculty will bring knowledge and understanding of the potential role Biosimilars are expected to play in treatment regiments in hematology to your Grand Rounds series, State Chapter Meeting, or other local event. Request a live meeting in your area now!

* = required field

Required Information

Contact Person:*

Type of Meeting:

Site Name:*

Site Address:*

Site Address:

City:*

State:*

ZIP:*

Phone:*

Contact E-mail:*

Would you like The France Foundation to provide CME accreditation?* Yes No, we will provide the accreditation

Is your institution able to accept an administrative stipend to assist with your implementation costs?* Yes No

Please list three available dates

Date:

Time:

Date:

Time:

Date:

Time:

Please list three potential speakers
(You may leave this blank if you would like us to provide recommendations):

Name:

Title:

Contact Info:

Name:

Title:

Contact Info:

Name

Title

Contact Info:

Audience Details

Audience/Specialty:

Anticipated number of attendees:

Do you wish to opt-in to receive future communications from The France Foundation?

You acknowledge personal information you provide may be used in accordance with our Privacy Policy*

ReCaptcha

New & Noteworthy

Newsfeed
Infliximab-qbtx Approved by FDA
READ MORE
Newsfeed
First Trastuzumab Biosimilar, Ogivri, Approved by FDA
READ MORE
CME/CE Webinars
Biosimilars Summary Based on FDA Approval: Differences Between Biosimilars and Generics
READ MORE

Live Meeting Request

Live Meeting Request

New & Noteworthy

Infliximab-qbtx Approved by FDA

First Trastuzumab Biosimilar, Ogivri, Approved by FDA

Biosimilars Summary Based on FDA Approval: Differences Between Biosimilars and Generics